Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe.
Damon WillemsEva-Lotta HinzpeterHessel H Van der ZeeChristopher J SayedJohn R IngramCharlotte BeaudartSilvia M A A EversMickaël J C HiligsmannPublished in: The patient (2023)
This study revealed the most important treatment characteristics for patients with hidradenitis suppurativa that can help inform joint patient-physician decision making in the management of hidradenitis suppurativa. Designing future hidradenitis suppurativa treatments according to stated preferences, namely, to offer higher levels of effectiveness and pain improvement without higher risks of adverse events, may increase patients' treatment concordance and lead to improved disease management outcomes.
Keyphrases
- hidradenitis suppurativa
- end stage renal disease
- randomized controlled trial
- case report
- systematic review
- chronic kidney disease
- primary care
- newly diagnosed
- ejection fraction
- spinal cord injury
- prognostic factors
- type diabetes
- metabolic syndrome
- peritoneal dialysis
- current status
- neuropathic pain
- adipose tissue
- single cell
- smoking cessation